Company news
Argent Biopharma Ltd news in 2019
Argent Biopharma Ltd's news releases, calls and decks from 2019, newest first.
First Shipment of CogniCann en route to Australia
December 18, 2019
Prescriptions Grow Above 1,800 & First Ireland Prescriptions
December 16, 2019
Approval Received for Distribution of CannEpil into Ireland
December 2, 2019
Growth in Prescriptions Issued Continues During November
November 25, 2019
Binding Term Sheet to Immediately Expand into Latin America
November 21, 2019
Pause in Trade
November 20, 2019
MGC Reaches 1,000 Prescription Milestone Ahead of Schedule
October 30, 2019
800 Prescription Milestone Passed for MGC Pharma Products
October 23, 2019
600 Prescription Milestone Passed for MGC Pharma Products
October 15, 2019
MGC Pharma Passes 400 Prescription Milestone in September
October 2, 2019
200 Prescription Milestone Passed in Australia & UK
September 17, 2019
Epilepsy Clinical Study Comparing CannEpil to 100% CBD
September 2, 2019
Placement Settlement Complete, Info on the Priority Offer
August 29, 2019
Appendix 4E and Audited 2019 Financial Report
August 28, 2019
Approval Granted for Large-Scale Research Project with IHPS
August 26, 2019
Trial on the Effect of CannEpil on Driver Competency
August 23, 2019
Canaccord to Lead LSE Listing and $4.75m Placement Closed
August 21, 2019
MXC 100 Patient Milestone in Aus, Onboards Tetra Health
August 12, 2019
MGC Signs Agreement for Construction of GMP Pharma Facility
August 8, 2019
Additional Information on Ground-breaking Research
July 29, 2019
MGC Research- Effectiveness of Cannabinoids on Brain Cancers
July 23, 2019
Germany, Austria & Switzerland Distribution Agreement Signed
June 21, 2019
Brazil Distribution Agreement signed for MGC Pharma Products
June 19, 2019
Pharma Update - Increased Orders and Clinical Study
June 12, 2019
Material Revenues Confirmed from Non-Pharma Business Units
June 4, 2019
Cultivation Licence Granted by the Office of Drug Control
May 28, 2019
Arrival of First CannEpil Shipment to United Kingdom
May 6, 2019
UK Distribution Agreement with Grow Biotech and IPS
May 5, 2019
New Distribution Agreements Signed for CannEpil & IMPs
May 2, 2019
Agreement for CBD Nutraceuticals Entry into China Market
April 17, 2019
Received CannEpil Purchase Orders and Import Permit for UK
April 11, 2019
MXCs 2019 Pharma Commercialisation Strategy
April 1, 2019
Independent Validation of MXC High-Grade Cannabis Genetics
February 25, 2019
MXC Botanical Update
January 31, 2019
Completion of MGC Derma Sale to CannaGlobal
January 28, 2019
Major Regulatory Milestones Achieved for Pharma Business
January 21, 2019